Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...

Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply. The ...

DUBLIN--(BUSINESS WIRE)--The "Global Viral Vector Production (Research-use) Market Size, Share & Trends Analysis Report by Vector Type (Adenovirus, AAV, Lentivirus), by Application, by Workflow, by ...

Bristol Myers Squibb’s cancer cell therapy Breyanzi. Johnson & Johnson and AstraZeneca’s recombinant COVID-19 vaccines. Novartis’ gene therapy Zolgensma. All of these, plus many others, are united by ...

Open-source vector database startup Qdrant Solutions GmbH today announced it has raised $50 million in early-stage funding to pave the way for smarter and more reactive artificial intelligence apps.

Qdrant, the open-source vector search engine built in Rust for production workloads, announced it has secured $50 million in Series B funding will enable composable vector search as core ...